Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-11-14 5:49 pm Sale | 13G | Lexeo Therapeutics Inc. LXEO | Lundbeckfond Invest A/S | 942,671 2.900% | -893,288 (-48.66%) | View |
| 2024-11-14 4:45 pm Purchase | 13G | Lexeo Therapeutics Inc. LXEO | Longitude Capital Partners IV LLC | 2,765,381 8.400% | 198,281 (+7.72%) | View |
| 2024-11-14 12:32 pm Purchase | 13G | Lexeo Therapeutics Inc. LXEO | JANUS HENDERSON GROUP PLC JHG | 3,763,195 11.400% | 369,908 (+10.90%) | View |
| 2024-11-14 12:23 pm Sale | 13G | Lexeo Therapeutics Inc. LXEO | EVENTIDE ASSET MANAGEMENT LLC | 1,855,986 5.610% | -336,225 (-15.34%) | View |
| 2024-11-12 09:31 am Purchase | 13G | Lexeo Therapeutics Inc. LXEO | Adage Capital Management L.P. | 2,597,736 7.860% | 2,597,736 (New Position) | View |
| 2024-08-09 09:43 am Sale | 13G | Lexeo Therapeutics Inc. LXEO | EVENTIDE ASSET MANAGEMENT LLC | 2,192,211 6.650% | -810,620 (-27.00%) | View |
| 2024-08-05 12:54 pm Purchase | 13G | Lexeo Therapeutics Inc. LXEO | JANUS HENDERSON GROUP PLC JHG | 3,393,287 10.300% | 1,062,549 (+45.59%) | View |
| 2024-02-14 4:57 pm Sale | 13G | Lexeo Therapeutics Inc. LXEO | CITADEL ADVISORS LLC | 2,084,267 7.800% | -8,221 (-0.39%) | View |
| 2024-02-14 4:43 pm Purchase | 13G | Lexeo Therapeutics Inc. LXEO | Omega Fund VI L.P. | 2,157,623 8.100% | 2,157,623 (New Position) | View |
| 2024-02-14 4:34 pm Purchase | 13G | Lexeo Therapeutics Inc. LXEO | Lundbeckfond Invest A/S | 1,835,959 6.900% | 1,835,959 (New Position) | View |
| 2024-02-14 1:43 pm Purchase | 13G | Lexeo Therapeutics Inc. LXEO | JANUS HENDERSON GROUP PLC JHG | 2,330,738 8.700% | 2,330,738 (New Position) | View |
| 2024-02-14 06:04 am Purchase | 13G | Lexeo Therapeutics Inc. LXEO | D1 Capital Partners L.P. | 2,506,607 9.400% | 2,506,607 (New Position) | View |
| 2024-02-13 4:43 pm Purchase | 13G | Lexeo Therapeutics Inc. LXEO | Longitude Capital Partners IV LLC | 2,567,100 9.600% | 2,567,100 (New Position) | View |
| 2023-12-15 4:51 pm Purchase | 13G | Lexeo Therapeutics Inc. LXEO | Novo Holdings A/S | 1,307,829 4.900% | 13,776 (+1.06%) | View |
| 2023-12-11 5:13 pm Purchase | 13G | Lexeo Therapeutics Inc. LXEO | EVENTIDE ASSET MANAGEMENT LLC | 3,002,831 11.930% | 3,002,831 (New Position) | View |
| 2023-11-24 4:33 pm Purchase | 13G | Lexeo Therapeutics Inc. LXEO | Novo Holdings A/S | 1,294,053 5.100% | 1,294,053 (New Position) | View |
| 2023-11-17 4:23 pm Purchase | 13G | Lexeo Therapeutics Inc. LXEO | CITADEL ADVISORS LLC | 2,092,488 8.300% | 2,092,488 (New Position) | View |